GH
UTHR icon

GAM Holding’s United Therapeutics UTHR Stock Holding History

GAM Holding’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-7,544
Closed -$885K – 944
2019
Q1 		$885K Buy
7,544
+4,721
+167% +$550K 0.04% 467
2018
Q4 		$307K Sell
2,823
-3,172
-53% -$368K 0.02% 693
2018
Q3 		$767K Sell
5,995
-1,566
-21% -$194K 0.03% 556
2018
Q2 		$856K Sell
7,561
-4,079
-35% -$448K 0.03% 527
2018
Q1 		$1.31M Sell
11,640
-8,935
-43% -$1.14M 0.05% 386
2017
Q4 		$3.04M Buy
20,575
+18,575
+929% +$2.36M 0.09% 263
2017
Q3 		$234K Sell
2,000
-11,289
-85% -$1.44M 0.01% 479
2017
Q2 		$1.72M Sell
13,289
-6,150
-32% -$767K 0.03% 528
2017
Q1 		$2.63M Sell
19,439
-800
-4% -$121K 0.04% 449
2016
Q4 		$2.9M Buy
20,239
+6,591
+48% +$842K 0.05% 394
2016
Q3 		$1.6M Sell
13,648
-7,400
-35% -$889K 0.03% 528
2016
Q2 		$2.23M Buy
21,048
+6,624
+46% +$739K 0.03% 489
2016
Q1 		$1.61M Buy
14,424
+4,760
+49% +$602K 0.03% 526
2015
Q4 		$1.51M Buy
9,664
+4,127
+75% +$601K 0.02% 576
2015
Q3 		$727K Buy
5,537
+72
+1% +$11.5K 0.01% 763
2015
Q2 		$951K Buy
5,465
+165
+3% +$29.7K 0.01% 753
2015
Q1 		$914K Sell
5,300
-6,900
-57% -$1.05M 0.01% 744
2014
Q4 		$1.58M Hold
12,200
– – 0.02% 563
2014
Q3 		$1.57M Buy
12,200
+300
+3% +$30.9K 0.02% 581
2014
Q2 		$1.05M Buy
11,900
+5,000
+72% +$481K 0.02% 698
2014
Q1 		$649K Hold
6,900
– – 0.01% 768
2013
Q4 		$780K Hold
6,900
– – 0.01% 632
2013
Q3 		$544K Hold
6,900
– – 0.01% 786
2013
Q2 		$454K Buy
+6,900
New +$444K 0.01% 654

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

GAM Holding's UTHR Position: Q2 2019 in Review

GAM Holding sold out of United Therapeutics (UTHR) in Q2 2019, closing a stake of 7,544 shares — an estimated $885K sold.

GAM Holding first reported a position in UTHR in Q2 2013 and held it in 24 quarters. The position peaked at $3.04M in Q4 2017. 320 funds tracked by Wall St. Rank hold UTHR as of Q2 2019.

  • GAM Holding reported no remaining United Therapeutics position as of Q2 2019 after selling out during the quarter.
  • GAM Holding sold 7,544 United Therapeutics shares in Q2 2019, an estimated $885K.
  • GAM Holding first reported a position in United Therapeutics in Q2 2013 and held it in 24 quarters.
  • GAM Holding's United Therapeutics position peaked at $3.04M in Q4 2017.
  • 320 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2019.

Based on GAM Holding's 13F filing for Q2 2019, filed 12 Aug 2019.